Influenza a infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor

42Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

A 68-year-old Japanese woman infected with influenza A developed thrombotic thrombocytopenic purpura (TTP) 2 days after having a fever. Routine laboratory tests on admission suggested a diagnosis of disseminated intravascular coagulation. However, ADAMTS13 assays showed an extremely low level of plasma ADAMTS13 activity with a high titer of anti-ADAMTS13 inhibitor (IgG). Despite high-dose methylprednisolone therapy with daily plasma exchange for 3 consecutive days, the patient died of pulmonary congestion complicated by cardiac failure. Our experience here provides the first evidence that influenza A infection is sufficient to trigger TTP by producing the anti-ADAMTS13 IgG inhibitor. © 2010 The Japanese Society of Internal Medicine.

Author supplied keywords

Cite

CITATION STYLE

APA

Kosugi, N., Tsurutani, Y., Isonishi, A., Hori, Y., Matsumoto, M., & Fujimura, Y. (2010). Influenza a infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor. Internal Medicine, 49(7), 689–693. https://doi.org/10.2169/internalmedicine.49.2957

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free